About: covid:PMC7245636

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7245636 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Zhang, Yi Cao, Bin Wang, Ke Hu, Yi Zhao, Jianping Cheng, Zhenshun Du, Ronghui Liu, Ying Wang, Chen Horby, Peter Hayden, Frederick Jin, Yang Fan, Guohui Wang, Yeming Lu, Yang Liu, Wen Gao, Ling Zhou, Fei Jaki, Thomas Ruan, Shunan Zhang, Dingyu Du, Guanhua Fu, Shouzhi Lu, Qiaofa Luo, Guangwei
is schema:about of	named entity 'EFFICACY' named entity 'MULTICENTRE TRIAL' named entity 'study protocol' named entity 'COVID-19' named entity 'double-blind, placebo-controlled' named entity 'RNA viruses' named entity 'Cox proportional hazards model' named entity 'Ke Wang' named entity 'ordinal scale' named entity 'Informed consent' named entity 'COVID' named entity 'aspirate' named entity 'stage III' named entity 'placebo' named entity 'China CDC' named entity 'eCRF' named entity 'Gilead Sciences, Inc.' named entity 'Wuhan' named entity 'lost to follow-up' named entity 'administrated' named entity 'invasive mechanical ventilation' named entity 'EDC' named entity 'informed consent' named entity 'alveolar' named entity 'tracheal' named entity 'infused intravenously' named entity 'COVID' named entity 'remdesivir' named entity 'Hangzhou' named entity 'SARS-CoV' named entity 'TTCI' named entity 'placebo' named entity 'remdesivir' named entity 'hospital discharge' named entity 'peritoneal' named entity 'Nasopharyngeal' named entity 'type I error' named entity 'pharmacy' named entity 'severe liver disease' named entity 'SAEs' named entity 'SARS-CoV' named entity 'data management' named entity 'Loading dose' named entity 'Treatment allocation' named entity 'estimated glomerular filtration rate' named entity 'barrier method' named entity 'lung' named entity 'remdesivir' named entity 'final analysis' named entity 'SARS' named entity 'principal investigator' named entity 'AST' named entity 'treatment group' named entity 'SAS software' named entity 'placebo' named entity 'infused intravenously' named entity 'test statistic' named entity 'mouse model' named entity 'cardiac arrest' named entity 'remdesivir' named entity 'TTCI' named entity 'virus disease' named entity 'remdesivir' named entity 'Unblinding' named entity 'sample size' named entity 'Wuhan' named entity 'logistic regression' named entity 'Independent Ethics Committee' named entity 'prodrug' named entity 'oxygen support' named entity 'MERS-CoV' named entity 'China' named entity 'oxygen support' named entity 'pharmacy' named entity 'control arm'

Attributes

Values

Creator

Zhang, Yi
Cao, Bin
Wang, Ke
Hu, Yi
Zhao, Jianping
Cheng, Zhenshun
Du, Ronghui
Liu, Ying
Wang, Chen
Horby, Peter
Hayden, Frederick
Jin, Yang
Fan, Guohui
Wang, Yeming
Lu, Yang
Liu, Wen
Gao, Ling
Zhou, Fei
Jaki, Thomas
Ruan, Shunan
Zhang, Dingyu
Du, Guanhua
Fu, Shouzhi
Lu, Qiaofa
Luo, Guangwei

is schema:about of

named entity 'EFFICACY'
named entity 'MULTICENTRE TRIAL'
named entity 'study protocol'
named entity 'COVID-19'
named entity 'double-blind, placebo-controlled'
named entity 'RNA viruses'
named entity 'Cox proportional hazards model'
named entity 'Ke Wang'
named entity 'ordinal scale'
named entity 'Informed consent'
named entity 'COVID'
named entity 'aspirate'
named entity 'stage III'
named entity 'placebo'
named entity 'China CDC'
named entity 'eCRF'
named entity 'Gilead Sciences, Inc.'
named entity 'Wuhan'
named entity 'lost to follow-up'
named entity 'administrated'
named entity 'invasive mechanical ventilation'
named entity 'EDC'
named entity 'informed consent'
named entity 'alveolar'
named entity 'tracheal'
named entity 'infused intravenously'
named entity 'COVID'
named entity 'remdesivir'
named entity 'Hangzhou'
named entity 'SARS-CoV'
named entity 'TTCI'
named entity 'placebo'
named entity 'remdesivir'
named entity 'hospital discharge'
named entity 'peritoneal'
named entity 'Nasopharyngeal'
named entity 'type I error'
named entity 'pharmacy'
named entity 'severe liver disease'
named entity 'SAEs'
named entity 'SARS-CoV'
named entity 'data management'
named entity 'Loading dose'
named entity 'Treatment allocation'
named entity 'estimated glomerular filtration rate'
named entity 'barrier method'
named entity 'lung'
named entity 'remdesivir'
named entity 'final analysis'
named entity 'SARS'
named entity 'principal investigator'
named entity 'AST'
named entity 'treatment group'
named entity 'SAS software'
named entity 'placebo'
named entity 'infused intravenously'
named entity 'test statistic'
named entity 'mouse model'
named entity 'cardiac arrest'
named entity 'remdesivir'
named entity 'TTCI'
named entity 'virus disease'
named entity 'remdesivir'
named entity 'Unblinding'
named entity 'sample size'
named entity 'Wuhan'
named entity 'logistic regression'
named entity 'Independent Ethics Committee'
named entity 'prodrug'
named entity 'oxygen support'
named entity 'MERS-CoV'
named entity 'China'
named entity 'oxygen support'
named entity 'pharmacy'
named entity 'control arm'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software